Meet the Editorial Board Member-Reference-Cited by-同舟云学术

Meet the Editorial Board Member

Published:2023-03 Issue:4 Volume:23 Page:379-379
ISSN:1389-5575
Container-title:Mini-Reviews in Medicinal Chemistry
language:en
Short-container-title:MRMC

Author:

Wuest Frank¹

Affiliation:

1. Department of Oncology, University of Alberta, Edmonton, AB Canada

Abstract

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,Pharmacology,General Medicine

Reference11 articles.

1. O. Tietz; A. Marshall; C. Bergman; M. Wuest; F. Wuest; Impact of Structural Alterations on the Radiopharmacological Profile of 18F-labeled Pyrimidines as Cyclooxygenase-2 (COX-2) Imaging Agents. Nucl Med Biol 2018,62-63,9-17

2. Hamann D.; Krys, V. Bouvet, D. Glubrecht, A. Marshall, C. Bergman, L. Vos, J. R. Mackey, M. Wuest, F. Wuest. Imaging hypoxia-driven regulation of metabolic markers in breast cancer: Role of GLUT1, GLUT2 and GLUT5. FASEB J In Press

3. B.J. Al-Hourani; B.F. Ali; Z. Judeh; M.I. El-Barghouthi; W. Al-Awaida; Y. Snobar; F. El Soubani; K. Matalqah; F. Wuest; Unexpected formation of 1-[4-chloromethylphenyl]-5-[4-(methyl-sulfonyl)benzyl]-1H-tetrazole and 1-[4-chloromethylphenyl]-5-[4-(aminosulfonyl)-phenyl]-1H-tetrazole: Crystal structure, bioassay screening and molecular docking studies. J Mol Struct 2018,1164,317-327

4. M. Wagner; M. Wuest; I. Hamann; A. Lopez-Campistrous; T. McMullen; F. Wuest; Molecular imaging of platelet-derived growth factor receptor-alpha (PDGFRa) in papillary thyroid cancer using immuno-PET. Nucl Med Biol 2018,58,51-58

5. M. Wuest; I. Hamann; V. Bouvet; D. Glubrecht; A. Marshall; B. Trayner; O-M. Soueidan; D. Krys; M. Wagner; C. Cheeseman; F. West; F. Wuest; Molecular Imaging of GLUT1 and GLUT5 in Breast Cancer: A Multitracer PET Imaging Study in Mice. Mol Pharmacol 2018,93,79-89